DalsnaFinance › IPOs › Lantern Pharma › IPO
Lantern Pharma Inc. completed its initial public offering on NASDAQ on June 11, 2020, pricing at $15.00 a share.
| Ticker | LTRN |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | June 11, 2020 |
| Offering price | $15.00 |
| Shares offered | 1,750,000 |
| Total raised | $26M |
Lantern Pharma Inc. sold 1,750,000 shares at $15.00 each on NASDAQ. Multiplied out, that is $26.3 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $26 million total recorded for the deal.
Lantern Pharma Inc. — quote, profile and latest news →
Source: SEC EDGAR filings for Lantern Pharma Inc.. This page is general information, not investment advice.